Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Heart Disease Deaths during the Covid-19 Pandemic

View ORCID ProfileJeremy S. Faust, Zhenqiu Lin, View ORCID ProfileHarlan M. Krumholz
doi: https://doi.org/10.1101/2020.06.04.20122317
Jeremy S. Faust
1Harvard Medical School, Brigham and Women’s Hospital Department of Emergency Medicine Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeremy S. Faust
  • For correspondence: jsfaust@gmail.com
Zhenqiu Lin
2Yale New Haven Hospital, Center for Outcomes Research and Evaluation New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harlan M. Krumholz
3Yale University School of Medicine, Yale New Haven Hospital, Center for Outcomes Research and Evaluation New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Harlan M. Krumholz
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The SARS-CoV-2 pandemic is associated with a reduction in hospitalization for an acute cardiovascular conditions. In a major health system in Massachusetts, there was a 43% reduction in these types of hospitalizations in March 2020 compared with March 2019.4 Whether mortality rates from heart disease have changed over this period is unknown.

We assembled information from the National Center for Health Statistics (Centers for Disease Control and Prevention) for 118,356,533 person-weeks from Week 1 (ending January 4) through Week 17 (ending April 25) of 2020 for the state of Massachusetts. We found that heart disease deaths are unchanged during the Covid-19 pandemic period as compared to the corresponding period of 2019. This is despite reports that admissions for acute myocardial infarction have fallen during this time.

The Covid-19 pandemic has been associated with a reduction in hospitalization for1,2,3,4 In a major health system in Massachusetts, there was a 43% reduction in these types of hospitalizations in March 2020 compared with March 2019.4 Whether mortality rates from heart disease have changed over this period is unknown.

Accordingly, we assembled data on weekly heart disease deaths in Massachusetts from the National Center for Health Statistics (Centers for Disease Control and Prevention) for 118,356,533 person-weeks from Week 1 (ending January 4) through Week 17 (ending April 25) of 2020.5 A total of 4,085 heart disease deaths were recorded during this period (incidence rate, 3.5 per 100,000 person-weeks; 95% confidence interval [CI] 3.4 to 3.6), versus 4,209 heart disease deaths over the same period in 2019 (incidence rate, 3.6 per 100,000 person-weeks; 95% CI, 3.5 to 3.7) (incidence rate ratio, 0.97; 95% CI, 0.92 to 1.01) (Figure 1). Covid-19 deaths and overall deaths from all causes, for comparison, markedly rose over the study period.

Figure 1.
  • Download figure
  • Open in new tab
Figure 1. Incidence of Heart Disease deaths before and during the Covid-19 Pandemic in 2020 and during the Same Period in 2019, Relative to the Incidence of deaths from Covid-19 and All-Cause Deaths during 2020.

Shown are data from Massachusetts. The data shown in orange are the reported weekly incidence rates of heart disease per 100,000 person-weeks during the period from Week 1 through Week 17, 2020. The data shown in blue are the reported weekly incidence rates of heart disease per 100,000 person-weeks during the period from Week 1 through Week 17, 2019. Embedded Image bars indicate 95% confidence intervals. The data shown in gray are the rates for Covid-19 deaths per 100,000 person-weeks for the same period, with the first Massachusetts death reported March 26, 2020. The data shown in yellow are the numbers of all-cause deaths per 100,000 person-weeks.

There are several feasible explanations for these findings. It is possible that some cardiovascular deaths could be incorrectly attributed and coded as Covid-19 deaths, though there is not routine post-mortem SARS-CoV-2 testing of patients who died in non-medical settings, nor instructions to medical officials to presume deaths of unknown cause to be coded as Covid-19-related in Massachusetts. The observed >40% decline in hospitalizations, while large, may not be associated with a decline in cardiovascular deaths, owing to the relatively low number of related modifiable deaths during the short time period of interest. There could be an actual decline in acute cardiovascular emergencies as a result of changes in exposures and behaviors during the Covid-19 shutdown. Finally, the reporting of cardiovascular deaths may not yet be sufficiently complete for 2020. However, the CDC reports that the currently available figures are estimated to be greater than 98.3% to 99.3% complete for the weeks reported here, and the final 0.7% to 1.7% is unlikely to change the qualitative conclusions (Supplementary Appendix, Table S1).6

These findings add more information to the pursuit of understanding the change in cardiovascular healthcare utilization during the Covid-19 outbreak in the United States but are unable to identify any definitive cause. For now, the information is at least reassuring that there was not a marked increase in cardiovascular deaths in Massachusetts during the early phase of the outbreak, despite a decrease in the number of patients seeking acute care for related emergencies. acute cardiovascular conditions.

Data Availability

The data is available to the public. https://www.cdc.gov/nchs/data/vsrr/report001.pdf

https://www.cdc.gov/nchs/data/vsrr/report001.pdf

References

  1. 1.↵
    Krumholz H. Where Have All the Heart Attacks Gone? The New York Times. https://www.nytimes.com/2020/04/06/well/live/coronavirus-doctors-hospitals-emergencycare-heart-attack-stroke.html.
  2. 2.↵
    Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic. J Am Coll Cardiol. 2020;75(22):2871–2872. doi:10.1016/j.jacc.2020.04.011
    OpenUrlFREE Full Text
  3. 3.↵
    Bhatt AS, Moscone A, McElrath EE, et al. Declines in Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic: A Multicenter Tertiary Care Experience. J Am Coll Cardiol. Published online May 21, 2020. doi:10.1016/j.jacc.2020.05.038
    OpenUrlFREE Full Text
  4. 4.↵
    Solomon MD, McNulty EJ, Rana JS, et al. The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction. N Engl J Med. Published online May 19, 2020:NEJMc2015630. doi:10.1056/NEJMc2015630
    OpenUrlCrossRefPubMed
  5. 5.↵
    CDC. Weekly Counts of Deaths by State and Select Causes, 2019–2020 | Data | Centers for Disease Control and Prevention. Accessed June 6, 2020. https://data.cdc.gov/NCHS/Weekly-Counts-of-Deaths-by-State-and-Select-Causes/muzy-jte6
  6. 6.↵
    Personal communication, The National Center for Health Statistics, United States Centers for Disease Control and Prevention. May 28, 2020.
Back to top
PreviousNext
Posted June 08, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Heart Disease Deaths during the Covid-19 Pandemic
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Heart Disease Deaths during the Covid-19 Pandemic
Jeremy S. Faust, Zhenqiu Lin, Harlan M. Krumholz
medRxiv 2020.06.04.20122317; doi: https://doi.org/10.1101/2020.06.04.20122317
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Heart Disease Deaths during the Covid-19 Pandemic
Jeremy S. Faust, Zhenqiu Lin, Harlan M. Krumholz
medRxiv 2020.06.04.20122317; doi: https://doi.org/10.1101/2020.06.04.20122317

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (452)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5268)
  • Forensic Medicine (3)
  • Gastroenterology (196)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (699)
  • Health Policy (360)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (164)
  • Infectious Diseases (except HIV/AIDS) (5889)
  • Intensive Care and Critical Care Medicine (363)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (767)
  • Nursing (43)
  • Nutrition (131)
  • Obstetrics and Gynecology (143)
  • Occupational and Environmental Health (234)
  • Oncology (480)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (98)
  • Psychiatry and Clinical Psychology (864)
  • Public and Global Health (2021)
  • Radiology and Imaging (349)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)